| Capital Raise Equity|| 1573|| Healthcare|| Exosome Diagnostics for Preterm Birth/Project Preview|| South Central|| Commercialization of novel maternal fetal medicine exosome platform. First-in-kind test predicts risk of premature birth as early as week 10. Uses simple blood draws obtained during standard checkup.|| Key partnerships with ThermoFisher, NIH, IU, and $12.5M already invested.|
| Capital Raise Equity|| 1676|| Healthcare|| Food Supplement Manufacturer/Project Super|| Northeast|| Contract OTC drug manufacturing and patent-protected superoxide dismutase-related supplements. FDA approval not req.|| $200M 2019 Rev.
$40M 2019 EBITDA|
| Capital Raise Debt|| 1717|| Technology / Media / Telecom|| Telecommunications Software Developer/Project LaSalle|| Midwest|| Company embeds software on phones to provide useful information about callers and to block spam.|| Partnered with Qualcomm|
| Capital Raise Equity|| 1704|| Healthcare|| Cancer Immunotherapy/Project Remedium|| West|| Clinical stage pharma with immunotherapy drug platform. Prostate cancer is first indication.|| Beginning Phase IIb/III clinical trials|
| M&A Sellside|| 1672|| Consumer / Retail|| Horticulture Equipment & Supplies Online Retailer/Project Alta|| West|| Sells equipment and supplies to both commercial and hobbyist cannabis cultivators. Non-plant touching. Unique media-driven strategy reduces CAC.|| $37.9M 2020F Rev.
$2.9M 2020 EBITDA
32% YoY growth|
| M&A Sellside|| 1542|| Aerospace & Defense / Government Services|| Engineering, Mtce., Repair & Overhaul (MRO) for Military Air Forces/Project Blue|| Southeast|| Provides engineering-centric solutions to US and foreign military air forces. Engineers, manufactures and repairs airframe parts solving mission-critical supply chain issues for fleet operations worldwide (both fixed wing and rotary).|| $25.0M 2019 Revs
$11.2M 2019 EBITDA
$25.5M 2020F Revs
$9.9M 2020P EBITDA|
| M&A Sellside|| 1615|| Technology / Media / Telecom|| Multi-Dwelling Unit Broadband Provider/Project Bandwidth|| Midwest|| Provider of broadband and cable to multi-dwelling units across seven states in the Midwest. Low churn. Long term contracts.|| ~10,000 PSUs
| Capital Raise Equity|| 1605|| Healthcare|| Semiconductor and Electronics Manufacturer/Project Milliard|| Midwest|| Advanced product authentication technology for logistics and anti-counterfeiting measures; compatible with blockchain and Internet of Things.|| Potential for EBITDA > $100M over the next several years|
| Capital Raise Equity|| 1302|| Healthcare|| Stroke Drug/Project Augur|| Israel|| Advance a proprietary intra-cranial hemorrhage (stroke) drug into clinical trials.|| Profitable biologics manufacturer|